Adjunctive therapy for ischemic wounds using cilostazol

Wounds

Volumn 15, Issue 3, 2003, Pages 77-82

  Carson, Stanley N ^a,b   Overall, Karen ^a  

^a Fountain Valley Regional Hospital and Medical Center   (United States)

^b Fountain Valley Regional Hospital ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CILOSTAZOL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEBRIDEMENT; DETERIORATION; FEMALE; HUMAN; INFORMED CONSENT; LEG ISCHEMIA; MALE; MOISTURE; RISK FACTOR; SCORING SYSTEM; STANDARD; TREATMENT OUTCOME; WOUND; WOUND CARE; WOUND HEALING;

EID: 0037359590     PISSN: 10447946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Dawson DL, Cutler BS, Meissner MH, Strandness DE, Jr. Cilostazol has beneficial effects in treatment of intermittent claudication: Results from a multicenter, randomized, prospective, double-blind trial. Circulation 1998;98(7):678-86.
2. Tsuchikane E, Fukuhara A, Kobayashi T, et al. Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty. Circulation 1999;100:21-6.
3. Money SR, Herd JA, Isaacsohn JL, et al. Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease. J Vasc Surg 1998;27(2):267-5.
4. Levine JM. Leg ulcers: Differential diagnosis in the elderly. Geriatrics 1990;45(6):32-42.
5. Nelzen O, Bergqvist D, Lindhagen A. High prevalence of diabetes in chronic leg ulcer patients: A cross-sectional population study. Diabet Med 1993;10(4):345-50.
6. Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation: Basis for prevention. Diabetes Care 1990;13(5):513-21.
7. Ebakov B, Josephsen P. Incidence of reamputation and death after gangrene of the lower extremity. Prosthet Orthotics Int 1980;4:77-81.
8. Ruckley CV. Socioeconomic impact of chronic venous insufficiency and leg ulcers. Angiology 1997;48(1):67-9.
9. Nehler MR, Whitehill TA, Steven P, et al. Intermediate-term outcome of primary digit amputations in patients with diabetes mellitus who have forefoot sepsis requiring hospitalization and presumed adequate circulatory status. J Vasc Surg 1999;30(3):509-18.
10. Reilly MP, Mohler ER III. Cilostazol: Treatment of intermittent claudication. Ann Pharmacother 2001;35(1):48-56.
11. Dawson DL, Cutler BS, Hiatt WR, et al. A comparison of cilostazol and pentoxifylline for treating intermittent claudication. Amer J Med 2000;109(7):523-30.
12. Okuda Y, Mizutani M, Ikegami T, Ueno E, Yamashita K. Hemodynamic effects of cilostazol on peripheral artery in patients with diabetic neuropathy. Arzneimittel-Forschung (German) 1992;42(4):540-2.
13. Kondo H, Mori S, Hori Y, et al. Clinical usefulness of cilostazol in the treatment of skin ulcer of patients with collagen diseases. Drug Eval 1994;14(6):537.
14. Arakawa K, Arada J. Clinical analysis of Pletal for intractable skin ulcer based on vascular damage and cutis symptom. Shin'yaku to Rinsho (J New Remedies Clin) (Japanese) 1993;42(1):60-8.
15. Pomposelli FB Jr, Marcaccio EJ, Gibbons GW, et al. Dorsalis pedis arterial bypass: Durable limb salvage for foot ischemia in patients with diabetes mellitus. J Vasc Surg 1995;21(3):375-84.
16. McCarthy WJ, Matsumura JS, Fine NA, Dumanian GA, Pearce WH. Combined arterial reconstruction and free tissue transfer for limb salvage. J Vasc Surg 1999;29(5):814-20.
17. Treiman GS, Oderich GS, Ashrafi A, Schneider PA. Management of ischemic heel ulceration and gangrene: An evaluation of factors associated with successful healing. J Vasc Surg 2000;31(6):1110-8.
18. Hafner J, Schaad I, Schneider E, et al. Leg ulcers in peripheral arterial disease (arterial leg ulcers): Impaired wound healing above the threshold of chronic critical limb ischemia. J Am Acad Dermatol 2000;43(6):1001-8.
19. Rich K. Transcutaneous oxygen measurements: Implications for nursing. J Vasc Nurs 2001;19(2):55-9.
20. Black J. Tissue oxygen perfusion and pressure ulcer healing. Plast Surg Nurs Spring 2000;20(1):10-24.